Semaglutide, reduction in HbA1c and the risk of diabetic retinopathy

Diabetes - GeneralDiabetic Complications

Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine

Diabetologia.

Eleuteri A, Fisher AC, Broadbent DM, García-Fiñana M, Cheyne CP, Wang A, Stratton IM, Gabbay M, Seddon D, Harding SP; Individualised Screening for Diabetic Retinopathy (ISDR) Study Group

doi: 10.1007/

Diabetic Complications

Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study

Diabetes Care.

Hainsworth DP, Bebu I, Aiello LP, Sivitz W, Gubitosi-Klug R, Malone J, White NH, Danis R, Wallia A, Gao X, Barkmeier AJ, Das A, Patel S, Gardner TW, Lachin JM, Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group

doi: 10.2337/dc18-2308.

Diabetes - GeneralType 2 DiabetesDiabetic Complications

Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy

Diabetes Care.

Douros A, Filion KB, Yin H, Yu OH, Etminan M, Udell JA, Azoulay L

doi: 10.2337/dc17-2280.

Type 1 DiabetesType 2 Diabetes

Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study

Diabetes Care.

Jaiswal M, Divers J, Dabelea D, Isom S, Bell RA, Martin CL, Pettitt DJ, Saydah S, Pihoker C, Standiford DA, Dolan LM, Marcovina S, Linder B, Liese AD, Pop-Busui R, Feldman EL

doi: 10.2337/dc17-0179.

Type 2 DiabetesDiabetic ComplicationsGlycemic Control

Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study.

Diabetes Care.

Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Eye Study Group and the Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Study Group

doi: 10.2337/dc16-0024.

Diabetes - GeneralType 2 DiabetesGlycemic Control

Blood Glucose Reduction by Diabetic Drugs with Minimal Hypoglycemia Risk for Cardiovascular Outcomes: Evidence from Meta-regression Analysis of Randomized Controlled Trials

Diabetes Obes Metab.

Huang CJ, Wang WT, Sung SH, Chen CH, Lip GY, Cheng HM, Chiang CE

doi: 10.1111/dom.13342.

Diabetes - GeneralType 2 DiabetesGlycemic Control

Complex Assessment of Metabolic Effectiveness of Insulin Pump Therapy in Patients with Type 2 Diabetes Beyond HbA1c Reduction

Diabetes Technol Ther.

Chlup R, Runzis S, Castaneda J, Lee SW, Nguyen X, Cohen O

doi: 10.1089/dia.2017.0283.

Diabetic Complications

Impact of Age of Onset, Puberty, and Glycemic Control Followed From Diagnosis on Incidence of Retinopathy in Type 1 Diabetes: The VISS Study

Diabetes Care.

Nordwall M, Fredriksson M, Ludvigsson J, Arnqvist HJ

doi: 10.2337/dc18-1950.

Diabetes - GeneralType 2 Diabetes

The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial

Diabetes Care.

Dhatariya K, Bain SC, Buse JB, Simpson R, Tarnow L, Kaltoft MS, Stellfeld M, Tornøe K, Pratley RE; LEADER Publication Committee on behalf of the LEADER Trial Investigators

doi: 10.2337/dc18-1094.

Related content

Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine

Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study

Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy

Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study

Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study.

Blood Glucose Reduction by Diabetic Drugs with Minimal Hypoglycemia Risk for Cardiovascular Outcomes: Evidence from Meta-regression Analysis of Randomized Controlled Trials

Complex Assessment of Metabolic Effectiveness of Insulin Pump Therapy in Patients with Type 2 Diabetes Beyond HbA1c Reduction

Impact of Age of Onset, Puberty, and Glycemic Control Followed From Diagnosis on Incidence of Retinopathy in Type 1 Diabetes: The VISS Study

The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial